A COVID-19 Antibody Cocktail Developed by Regeneron and Roche Reduced the Mortality Rate ... - Latest Tweet by Reuters

A COVID-19 antibody cocktail developed by Regeneron and Roche reduced the mortality rate in hospitalized patients, a British study found. The trial's chief investigator said the treatment also reduced patients' chances of needing a mechanical ventilator https://t.co/zQFS1zlLGX pic.twitter.com/RXElBqpkdh— Reuters (@Reuters) June 16, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)